复发性心膜炎:复发的预测,风险分数,以及运动限制的作用
Joseph El Roumi1, Jibran Ikram1, Tom Kai Ming Wang1
1Center for Diagnosis and Treatment of Pericardial Diseases, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Methodist DeBakey cardiovascular journal
|March 16, 2026
概括
复发性心膜炎 (RP) 是一种复发性炎症性心脏病. 本综述涵盖了预测因素,风险评分和炼策略,用于管理RP以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 炎症性疾病 炎症性疾病
背景情况:
- 复发性心膜炎 (RP) 的特点是经常出现的急性心膜炎爆发.
- RP影响15-30%的初始急性心膜炎病例,复发率高.
- RP导致显著的发病率,降低生活质量,以及潜在的并发症,如心脏栓塞.
研究的目的:
- 审查关于临床前景,预测因素和RP复发风险分层的当前知识.
- 批判性地评估运动限制在RP管理中的作用.
- 要总结治疗复发性心膜炎的不断发展的策略.
主要方法:
- 临床试验,观察研究和RP管理方面的专家经验的文献综述.
- 从临床,实验室和成像数据中分析识别的预后因素.
- 评估最近开发的风险评分 (雅典,托里诺,INFLA,克莱恩) 和运动限制指南.
主要成果:
- 已经确定了许多RP的不良预测因素.
- 对于RP风险分层和治疗指导,有几种风险得分可用.
- 有证据支持在多式联络式RP治疗中个性化的运动限制策略.
结论:
- 多中心验证和随机试验对于风险得分和运动限制是必要的.
- 更好地理解和应用风险分层和炼指导可以提高RP患者的结果.
相关概念视频
Aortic Regurgitation III: Medical Management
537
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
537
Pericarditis III: Medical Management
480
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
480
Myocarditis III: Medical Management
309
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
309
Pericarditis II: Clinical Features and Diagnostic Tests
491
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
491
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
903
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
903
Rheumatic Heart Disease IV: Nursing Management
426
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
426


